Abstract
SummaryBoth subcutaneous (100 mg/kg day) and oral (300 mg/kg day) treatment of rats for 2 days with the compound, o,p′-DDD, shortened pentobarbital sleeping time. Hepatic metabolism of pentobarbital was measured in liver slices taken from these animals after 3 days of treatment and found to be significantly increased. Concomitant treatment with ethionine (150 mg/kg), an inhibitor of protein synthesis, blocked the effects of o,p′-DDD on both sleeping time and in vitro hepatic metabolism of pentobarbital. On the basis of these criteria it is suggested that o,p′-DDD induces hepatic enzymes which metabolize pentobarbital.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
